Our Latest Articles

The healthcare sector’s overwhelming complacency with current female hormonal contraceptives has resulted in a lack of innovation for new methods. Between 2017 and 2020, pharmaceutical companies funded only 20-25 clinical trials worldwide for contraception options, with most studies focusing on incremental changes to existing hormonal contraception options. By comparison, For some women who use hormonal contraception, serious side effects can emerge, and alternative options a